Association between asthma and rhinitis according to atopic sensitization in a population-based study - 24/08/11
on behalf of the European Community Respiratory Health Survey
Abstract |
Background |
Although asthma and rhinitis often occur together, the reason for this common comorbidity is still a matter of debate.
Objective |
We sought to assess whether the coexistence of asthma and rhinitis could be explained by common risk factors.
Methods |
International cross-sectional study of representative samples of young adults, who completed a detailed questionnaire and underwent lung function tests, bronchoprovocation challenge, IgE measurements, and skin prick tests.
Results |
In all countries, asthma and bronchial hyperreactivity were more frequent in subjects with rhinitis than in those without (odds ratio [OR], 6.63; 95% CI, 5.44-8.08; and OR, 3.02 95% CI, 2.66-3.43, respectively). Seventy-four percent to 81% of subjects with asthma reported rhinitis, depending on sensitization to specific allergens. Conversely, the risk of asthma increased from 2.0% in subjects without rhinitis to 6.7% in subjects with rhinitis only when exposed to pollen, 11.9% in subjects with rhinitis when exposed to animals, and 18.8% in subjects with rhinitis either when exposed to pollen or to animals. The association between rhinitis and asthma remained significant after adjustment for total IgE, parental history of asthma, and allergen sensitization (OR, 3.41; 95% CI, 2.75-4.2 suggesting that the coexistence of asthma and rhinitis is not solely due to atopic predisposition to these 2 diseases.
Conclusions |
Although there were some variations in the association between asthma and rhinitis according to sensitization to individual allergens, the strong association between asthma and rhinitis was not fully explained by shared risk factors, including atopy. Our findings are consistent with the hypothesis that rhinitis might increase the risk of asthma.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Epidemiology, rhinitis, asthma, pollen, allergens, hypersensitivity, bronchial hyperreactivity
Abbreviations : BHR, ECRHS, OR
Mappa
| The following grants helped to fund the local studies: Australia: Allen and Hanbury's, Australia. Belgium: Belgian Science Policy Office, National Fund for Scientific Research. France: Ministère de la Santé, Glaxo France, Institut Pneumologique d'Aquitaine, Contrat de Plan Etat-Région Languedoc-Roussillon, CNMATS, CNMRT (90MR/10, 91AF/6), Ministre délégué de la santé, RNSP. Germany: GSF, and the Bundesminister für Forschung und Technologie, Bonn. Greece: The Greek Secretary General of Research and Technology, Fisons, Astra, and Boehringer-Ingelheim. India: Bombay Hospital Trust. Italy: Ministero dell'Univesitàe della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93. New Zealand: Asthma Foundation of New Zealand, Lotteries Grant Board, Health Research Council of New Zealand. Norway: Norwegian Research Council project no. 101422/310. Portugal: Glaxo Farmacêutica Lda, Sandoz Portugesa. Spain: Ministero Sanidad y Consumo FIS (grants #91/0016060/OOE-05E., #92/0319, #93/0393), Hospital General de Albacete, Hospital General Juan Ramón Jiménenz, Consejeria de Sanidad Principado de Asturias. Sweden: The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy, The Swedish Society of Medicine, Astra, Glaxo-Wellcome, Boehringer-Ingelheim. Switzerland: Swiss National Science Foundation grant 4026-28099. United Kingdom: National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority. United States: United States Department of Health, Education and Welfare Public Health Service Grant #2 S07 RR05521-28. Special thanks to UCB-Pharma-France for their financial support for this analysis. |
Vol 113 - N° 1
P. 86-93 - gennaio 2004 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
